Organon & Co. (OGN)
13.79
+0.05
(+0.36%)
USD |
NYSE |
Oct 07, 16:00
13.78
-0.01
(-0.07%)
Pre-Market: 20:00
Organon Total Liabilities (Quarterly) : 12.17B for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.17B |
| March 31, 2026 | 12.09B |
| December 31, 2025 | 12.12B |
| September 30, 2025 | 12.65B |
| June 30, 2025 | 12.77B |
| March 31, 2025 | 12.61B |
| December 31, 2024 | 12.63B |
| September 30, 2024 | 12.26B |
| June 30, 2024 | 12.01B |
| March 31, 2024 | 11.84B |
| December 31, 2023 | 12.13B |
| September 30, 2023 | 11.60B |
| Date | Value |
|---|---|
| June 30, 2023 | 11.53B |
| March 31, 2023 | 11.50B |
| December 31, 2022 | 11.85B |
| September 30, 2022 | 11.50B |
| June 30, 2022 | 11.75B |
| March 31, 2022 | 11.85B |
| December 31, 2021 | 12.19B |
| September 30, 2021 | 12.95B |
| June 30, 2021 | 12.84B |
| March 31, 2021 | 4.92B |
| December 31, 2020 | 4.623B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 87.82B |
| Pfizer Inc. | 115.64B |
| Bristol Myers Squibb Co. | 65.32B |
| Harmony Biosciences Holdings, Inc. | 373.84M |
| ANI Pharmaceuticals, Inc. | 896.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.18B |
| Shareholders Equity (Quarterly) | 1.006B |
| Debt to Equity Ratio | 8.502 |
| Current Ratio | 1.954 |
| Net Debt Paydown Yield | 2.27% |